Olysio (simeprevir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olysio (simeprevir), covering 2014-04-23 to 2014-04-23. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy [Phase 3]